(Q39690398)
Statements
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update (English)
L R Silverman
G J Mufti
E Hellström-Lindberg
N Gattermann
G Sanz
S D Gore
J F Seymour
J Backstrom
D McKenzie
8 December 2008